LRRK2 and Alzheimer disease: Overall, our findings indicated that LRRK2 kinase activity regulates amyloid-β-mediated astrocytic activation and functionality and, importantly, suggested that LRRK2 might contribute to AD-related neuroinflammation and pathogenesis.